↓ Skip to main content

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody

Overview of attention for article published in BMC Cancer, June 2012
Altmetric Badge

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Expanded clinical and experimental use of SOX11 - using a monoclonal antibody
Published in
BMC Cancer, June 2012
DOI 10.1186/1471-2407-12-269
Pubmed ID
Authors

Lena Nordström, Ulrika Andréasson, Mats Jerkeman, Michael Dictor, Carl Borrebaeck, Sara Ek

Abstract

The transcription factor SOX11 is of diagnostic and prognostic importance in mantle cell lymphoma (MCL) and epithelial ovarian cancer (EOC), respectively. Thus, there is an unmet clinical and experimental need for SOX11-targeting assays with low background, high specificity and robust performance in multiple applications, including immunohistochemistry (IHC-P) and flow cytometry, which until now has been lacking.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Other 3 14%
Researcher 3 14%
Student > Postgraduate 2 10%
Professor > Associate Professor 2 10%
Student > Master 2 10%
Other 5 24%
Unknown 4 19%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Biochemistry, Genetics and Molecular Biology 4 19%
Nursing and Health Professions 2 10%
Unspecified 1 5%
Agricultural and Biological Sciences 1 5%
Other 1 5%
Unknown 5 24%